Search - tctmd.com

Displaying 81 - 100 of 148

Sort: Relevancy | Date

Presentation TCT 2016

Poland Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure?

Presenter: Dariusz Dudek, Petr Kala, Andrzej J. Ochala

October 30, 2016

Presentation TCT 2016

Germany Presents: Treatment Options - Should Severe Mitral Regurgitation be Treated Prior, During or After TAVR (and in a Single or Staged Procedures)?

Presenter: Dariusz Dudek, Petr Kala, Holger Thiele

October 30, 2016

Presentation TCT 2016

Introduction and Session Objectives

Presenter: Dariusz Dudek, Petr Kala

October 30, 2016

Presentation TCT 2016

Czech Republic Presents: How Did I Treat This Case?

Presenter: Eric Van Belle, Jochen Wöhrle, Marian Branny

October 30, 2016

Presentation TCT 2016

Poland Responds: How Would I Treat This Case?

Presenter: Eric Van Belle, Jochen Wöhrle, Marek Grygier

October 30, 2016

Presentation TCT 2016

Czech Republic Presents: A Case of Ostial LAD Undergoing TAVR: Staged or Single Procedure?

Presenter: Eric Van Belle, Jochen Wöhrle, Marian Branny

October 30, 2016

Presentation TCT 2016

France Presents: How Did I Treat This Case?

Presenter: Eric Van Belle, Jochen Wöhrle, Flavien Vincent

October 30, 2016

Presentation TCT 2016

France Presents: A Patient With Critical CAD and Aortic Stenosis Undergoing TAVR: Staged or Single Procedure?

Presenter: Eric Van Belle, Jochen Wöhrle, Flavien Vincent

October 30, 2016

Presentation TCT 2016

Poland Presents: Treatment Options - Should Severe Coronary Artery Disease Be Treated Prior, During, or After TAVR (and in a Single or Staged Procedure)?

Presenter: Eric Van Belle, Jochen Wöhrle, Dariusz Dudek

October 30, 2016

Presentation TCT 2016

Introduction and Session Objectives

Presenter: Eric Van Belle, Jochen Wöhrle

October 30, 2016

Presentation TVT 2016

Be Prepared! The Management of Vascular Complications After Transfemoral TAVR

Presenter: James M. McCabe

June 16, 2016

Presentation TVT 2016

Step-by-Step: Vascular Screening, Transfemoral Access Techniques, and Percutaneous Closure After TAVR

Presenter: Jonathon M. White

June 16, 2016

Presentation

Incidence, Predictors, and Outcome of Patients Developing Infective Endocarditis (IE) Following Transfemoral TAVR

Presenter: Norman Mangner

June 14, 2016

Presentation Aortovascular 2015

Transfemoral TAVR: Current indications and results

Presenter: Susheel K. Kodali

September 19, 2015

Presentation

Vascular Complications, Bleeding After Transfemoral TAVR Performed Through Open Surgical Access

Presenter: Florence Leclercq

September 11, 2015

Presentation

Comparison of Vascular Closure Devices for Access-Site Closure After Transfemoral TAVR

Presenter: IM Barbash

September 03, 2015

Presentation

1-Year Outcomes After Transfemoral TAVR or Surgery

Presenter: C. Tamburino

August 10, 2015

Presentation

Early Discharge After Transfemoral TAVR

Presenter: Marco Barbanti

June 23, 2015

Presentation TVT 2015

New Transfemoral Access Closure Devices

Presenter: Eberhard Grube

June 05, 2015

Presentation TVT 2015

Avoiding and Managing Transfemoral Vascular Complications

Presenter: Augusto D. Pichard

June 05, 2015

Advertisement

Poland Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure?

Germany Presents: Treatment Options - Should Severe Mitral Regurgitation be Treated Prior, During or After TAVR (and in a Single or Staged Procedures)?

Introduction and Session Objectives

Czech Republic Presents: How Did I Treat This Case?

Poland Responds: How Would I Treat This Case?

Czech Republic Presents: A Case of Ostial LAD Undergoing TAVR: Staged or Single Procedure?

France Presents: How Did I Treat This Case?

France Presents: A Patient With Critical CAD and Aortic Stenosis Undergoing TAVR: Staged or Single Procedure?

Poland Presents: Treatment Options - Should Severe Coronary Artery Disease Be Treated Prior, During, or After TAVR (and in a Single or Staged Procedure)?

Introduction and Session Objectives

Be Prepared! The Management of Vascular Complications After Transfemoral TAVR

Step-by-Step: Vascular Screening, Transfemoral Access Techniques, and Percutaneous Closure After TAVR

Incidence, Predictors, and Outcome of Patients Developing Infective Endocarditis (IE) Following Transfemoral TAVR

Transfemoral TAVR: Current indications and results

Vascular Complications, Bleeding After Transfemoral TAVR Performed Through Open Surgical Access

Comparison of Vascular Closure Devices for Access-Site Closure After Transfemoral TAVR

1-Year Outcomes After Transfemoral TAVR or Surgery

Early Discharge After Transfemoral TAVR

New Transfemoral Access Closure Devices

Avoiding and Managing Transfemoral Vascular Complications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content